BIOXCEL THERAPEUTICS INC. - COMMON STOCK
1,0550
05-июля-24 13:19:30
15 мин. задержка
Акции
-0,0250
-2,31%
Сегодняшний диапазон
1,0350 - 1,1200
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
BioXcel Therapeutics to Present at Jefferies Global Healthcare Conference
28 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
21 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
BioXcel Therapeutics Reports First Quarter 2024 Financial Results
09 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Report First Quarter 2024 Financial Results on May 9, 2024
25 апр 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
24 апр 2024 10:30:24 Источник Nasdaq GlobeNewswire
-
22 апр 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
10 апр 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
BioXcel Therapeutics Announces $25 Million Registered Direct Offering
25 мар 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
15 мар 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
BioXcel Therapeutics Reports Financial Results for the Fourth Quarter and Full Year 2023
12 мар 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
01 мар 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
BioXcel Therapeutics Announces Termination of Proposed Public Offering
13 фев 2024 09:00:43 Источник Nasdaq GlobeNewswire
-
12 фев 2024 07:14:31 Источник Nasdaq GlobeNewswire
-
BioXcel Therapeutics Announces Proposed Public Offering
08 фев 2024 16:01:00 Источник Nasdaq GlobeNewswire
-
06 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
05 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
BioXcel Therapeutics Hosting Virtual Neuroscience R&D Day Today
12 дек 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
BioXcel Therapeutics Strengthens Clinical Development Leadership to Advance Late-Stage Programs
11 дек 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
BioXcel Therapeutics to Host Virtual Neuroscience R&D Day on Dec. 12, 2023
30 ноя 2023 07:00:00 Источник Nasdaq GlobeNewswire
- <<
- <
- 1
- >